MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) Operating margin 2016–2024
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) operating margin by fiscal year — reported operating income divided by reported revenue.
-2243.9%FY2024 · since FY2016: -4245.4% → -2243.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -2243.9% | -1498.4 pp |
| FY2023 | -745.5% | +73769.7 pp |
| FY2022 | -74515.2% | -58893.0 pp |
| FY2021 | -15622.1% | +11330.3 pp |
| FY2020 | -26952.5% | -11152.0 pp |
| FY2019 | -15800.4% | -6015.7 pp |
| FY2018 | -9784.8% | — |
| FY2016 | -4245.4% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice